Estimates Revisions Jamjoom Pharmaceuticals Factory Company
Stocks
4015
SA15QGU1UNH6
Pharmaceuticals
|
Market Closed -
Saudi Arabian S.E.
16:20:00 22/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 132.80 SAR | +0.08% |
|
+0.84% | -6.68% |
| 08-27 | Aljazira Capital Reduces Jamjoom Pharmaceuticals PT, Keeps at Neutral | MT |
| 08-27 | JamJoom Pharmaceuticals Kept at Neutral as AlJazira Capital Notes Q2 Results | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 4015 Stock
- Consensus Jamjoom Pharmaceuticals Factory Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
